Could a monthly shot beat biweekly for lowering cholesterol?
Disease control
Not yet recruiting
This study looks at two different dosing schedules of the drug tafolecimab—given every two weeks or every three weeks—in people with high cholesterol that isn't controlled by statins alone. Over 12 weeks, researchers will measure how much LDL (bad) cholesterol drops and how safe …
Sponsor: Mei Gao • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC